PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Clinical trial NCT00303953 · COMPLETED

Trial details

NCT number: NCT00303953
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma

Start date: 2006-01-01
Primary completion: 2010-01-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.